Takeda Pharmaceutical Company Limited. (NYSE:TAK) Q3 2022 Earnings Conference Call February 3, 2022 6:00 AM ET Corporate Participants Christopher OÂ'Reilly - Global Head, IR & Global Finance Christophe Weber - President and Chief Executive Officer Andy Plump - President Research and Development Costa Saroukos - Chief Financial Officer Masato Iwasaki - Japan General Affairs Ramona Sequeira - President, U.S. Business Unit and Global Portfolio Commercialization Julie Kim - President, Plasma-Derived Therapies B ...